Tag: thrombolytic agent
Tenecteplase becomes first new stroke medicine to gain Health Canada approval...
Hoffmann-La Roche (Roche Canada) announced this week that Health Canada has granted market authorisation for its TNKase brand of tenecteplase—a thrombolytic agent—in the treatment...
TargED doses first participant in Phase 1 clinical trial of “groundbreaking”...
TargED Biopharmaceuticals has today announced that it has commenced clinical development with the dosing of the first participant with TGD001—a “groundbreaking” thrombolytic designed to...
Basking Biosciences to present trial data on novel reversible thrombolytic agent...
Basking Biosciences has announced that it will be presenting three oral presentations and two moderated posters concerning the company’s novel drug candidate—a reversible thrombolytic...
European Stroke Organisation taskforce delivers update on thrombolytic drug shortages
The thrombolysis taskforce of the European Stroke Organisation (ESO) executive committee has provided an update on current shortages of alteplase and tenecteplase, detailing outcomes...
